RecallDepth
Class III Terminated

Candesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDC 0378-3002-77) and b) 500-count bottles (NDC 0378-3002-05), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

This recall has been terminated (originally issued October 28, 2020).

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
October 2, 2020
Posted
October 28, 2020
Recall Number
D-0049-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,695 bottles
Firm Location
Morgantown, WV, United States
Official Source
View on FDA website ↗

Reason for Recall

Out-of-specification organic impurity results obtained during routine stability testing.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: a) 8095666, Exp. Date July 2021 b) 3104664, Exp. Date July 2021

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls